Anoro Ellipta 62.5 ug/1
umeclidinium bromide and vilanterol trifenatate · POWDER · GlaxoSmithKline LLC
No Recall History
Plain English
Anoro Ellipta is a powder containing umeclidinium bromide and vilanterol trifenatate at 62.5 ug/1, taken respiratory (inhalation). Manufactured by GlaxoSmithKline LLC.
Key Facts
- Brand Name
- Anoro Ellipta
- Generic Name
- umeclidinium bromide and vilanterol trifenatate
- NDC Code (Product)
0173-0869- Manufacturer
- GlaxoSmithKline LLC
- Strength
- 62.5 ug/1
- Dosage Form
- POWDER
- Route
- RESPIRATORY (INHALATION)
- Marketing Status
- Application #
- NDA203975
- Marketing Start
- 01/31/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is Anoro Ellipta used for?
Anoro Ellipta contains umeclidinium bromide and vilanterol trifenatate. It is a powder taken respiratory (inhalation). Consult your doctor for specific uses.
Is Anoro Ellipta a controlled substance?
Anoro Ellipta is not classified as a controlled substance by the DEA.
What is the generic name for Anoro Ellipta?
The generic name for Anoro Ellipta is umeclidinium bromide and vilanterol trifenatate. There are 1 other brand versions of umeclidinium bromide and vilanterol trifenatate.
What is the NDC code for Anoro Ellipta 62.5 ug/1?
The NDC (National Drug Code) for Anoro Ellipta 62.5 ug/1 is 0173-0869, listed by GlaxoSmithKline LLC.